268 related articles for article (PubMed ID: 35708626)
21. COVID-19 in unvaccinated patients with inborn errors of immunity-polish experience.
Kołtan S; Ziętkiewicz M; Grześk E; Becht R; Berdej-Szczot E; Cienkusz M; Ewertowska M; Heropolitańska-Pliszka E; Krysiak N; Lewandowicz-Uszyńska A; Mach-Tomalska M; Matyja-Bednarczyk A; Milchert M; Napiórkowska-Baran K; Pieniawska-Śmiech K; Pituch-Noworolska A; Renke J; Roliński J; Rywczak I; Stelmach-Gołdyś A; Strach M; Suchanek H; Sulicka-Grodzicka J; Szczawińska-Popłonyk A; Tokarski S; Więsik-Szewczyk E; Wolska-Kuśnierz B; Zeman K; Pac M
Front Immunol; 2022; 13():953700. PubMed ID: 36211407
[TBL] [Abstract][Full Text] [Related]
22. Human IRF1 governs macrophagic IFN-γ immunity to mycobacteria.
Rosain J; Neehus AL; Manry J; Yang R; Le Pen J; Daher W; Liu Z; Chan YH; Tahuil N; Türel Ö; Bourgey M; Ogishi M; Doisne JM; Izquierdo HM; Shirasaki T; Le Voyer T; Guérin A; Bastard P; Moncada-Vélez M; Han JE; Khan T; Rapaport F; Hong SH; Cheung A; Haake K; Mindt BC; Pérez L; Philippot Q; Lee D; Zhang P; Rinchai D; Al Ali F; Ahmad Ata MM; Rahman M; Peel JN; Heissel S; Molina H; Kendir-Demirkol Y; Bailey R; Zhao S; Bohlen J; Mancini M; Seeleuthner Y; Roelens M; Lorenzo L; Soudée C; Paz MEJ; González ML; Jeljeli M; Soulier J; Romana S; L'Honneur AS; Materna M; Martínez-Barricarte R; Pochon M; Oleaga-Quintas C; Michev A; Migaud M; Lévy R; Alyanakian MA; Rozenberg F; Croft CA; Vogt G; Emile JF; Kremer L; Ma CS; Fritz JH; Lemon SM; Spaan AN; Manel N; Abel L; MacDonald MR; Boisson-Dupuis S; Marr N; Tangye SG; Di Santo JP; Zhang Q; Zhang SY; Rice CM; Béziat V; Lachmann N; Langlais D; Casanova JL; Gros P; Bustamante J
Cell; 2023 Feb; 186(3):621-645.e33. PubMed ID: 36736301
[TBL] [Abstract][Full Text] [Related]
23. Inherited IFNAR1 deficiency in otherwise healthy patients with adverse reaction to measles and yellow fever live vaccines.
Hernandez N; Bucciol G; Moens L; Le Pen J; Shahrooei M; Goudouris E; Shirkani A; Changi-Ashtiani M; Rokni-Zadeh H; Sayar EH; Reisli I; Lefevre-Utile A; Zijlmans D; Jurado A; Pholien R; Drutman S; Belkaya S; Cobat A; Boudewijns R; Jochmans D; Neyts J; Seeleuthner Y; Lorenzo-Diaz L; Enemchukwu C; Tietjen I; Hoffmann HH; Momenilandi M; Pöyhönen L; Siqueira MM; de Lima SMB; de Souza Matos DC; Homma A; Maia MLS; da Costa Barros TA; de Oliveira PMN; Mesquita EC; Gijsbers R; Zhang SY; Seligman SJ; Abel L; Hertzog P; Marr N; Martins RM; Meyts I; Zhang Q; MacDonald MR; Rice CM; Casanova JL; Jouanguy E; Bossuyt X
J Exp Med; 2019 Sep; 216(9):2057-2070. PubMed ID: 31270247
[TBL] [Abstract][Full Text] [Related]
24. Fatal COVID-19 Infection in Two Children with STAT1 Gain-of-Function.
Staines-Boone AT; Vignesh P; Tsumura M; de la Garza Fernández G; Tyagi R; Rawat A; Das J; Tomomasa D; Asano T; Hijikata A; Salazar-Gálvez Y; Kanegane H; Okada S; Reyes SOL
J Clin Immunol; 2023 Dec; 44(1):20. PubMed ID: 38129739
[TBL] [Abstract][Full Text] [Related]
25. COVID-19 in the Context of Inborn Errors of Immunity: a Case Series of 31 Patients from Mexico.
Castano-Jaramillo LM; Yamazaki-Nakashimada MA; O'Farrill-Romanillos PM; Muzquiz Zermeño D; Scheffler Mendoza SC; Venegas Montoya E; García Campos JA; Sánchez-Sánchez LM; Gámez González LB; Ramírez López JM; Bustamante Ogando JC; Vásquez-Echeverri E; Medina Torres EA; Lopez-Herrera G; Blancas Galicia L; Berrón Ruiz L; Staines-Boone AT; Espinosa-Padilla SE; Segura Mendez NH; Lugo Reyes SO
J Clin Immunol; 2021 Oct; 41(7):1463-1478. PubMed ID: 34114122
[TBL] [Abstract][Full Text] [Related]
26. Human genetics of SARS-CoV-2 infection and critical COVID-19.
Mogensen TH
Clin Microbiol Infect; 2022 Nov; 28(11):1417-1421. PubMed ID: 35218979
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of Genetic or Cellular Impairments in Type I IFN Immunity in a Cohort of Young Adults with Critical COVID-19.
Covill LE; Sendel A; Campbell TM; Piiroinen I; Enoksson SL; Borgström EW; Hansen S; Ma K; Marits P; Norlin AC; Smith CIE; Kåhlin J; Eriksson LI; Bergman P; Bryceson YT
J Clin Immunol; 2024 Jan; 44(2):50. PubMed ID: 38231281
[TBL] [Abstract][Full Text] [Related]
28. Comparison by Age of the Local Interferon Response to SARS-CoV-2 Suggests a Role for IFN-ε and -ω.
Pierangeli A; Gentile M; Oliveto G; Frasca F; Sorrentino L; Matera L; Nenna R; Viscido A; Fracella M; Petrarca L; D'Ettorre G; Ceccarelli G; Midulla F; Antonelli G; Scagnolari C
Front Immunol; 2022; 13():873232. PubMed ID: 35903094
[TBL] [Abstract][Full Text] [Related]
29. Untuned antiviral immunity in COVID-19 revealed by temporal type I/III interferon patterns and flu comparison.
Galani IE; Rovina N; Lampropoulou V; Triantafyllia V; Manioudaki M; Pavlos E; Koukaki E; Fragkou PC; Panou V; Rapti V; Koltsida O; Mentis A; Koulouris N; Tsiodras S; Koutsoukou A; Andreakos E
Nat Immunol; 2021 Jan; 22(1):32-40. PubMed ID: 33277638
[TBL] [Abstract][Full Text] [Related]
30. Neutralizing Autoantibodies to Type I IFNs in >10% of Patients with Severe COVID-19 Pneumonia Hospitalized in Madrid, Spain.
Troya J; Bastard P; Planas-Serra L; Ryan P; Ruiz M; de Carranza M; Torres J; Martínez A; Abel L; Casanova JL; Pujol A
J Clin Immunol; 2021 Jul; 41(5):914-922. PubMed ID: 33851338
[TBL] [Abstract][Full Text] [Related]
31. Type I and III IFN-mediated antiviral actions counteracted by SARS-CoV-2 proteins and host inherited factors.
Quarleri J; Delpino MV
Cytokine Growth Factor Rev; 2021 Apr; 58():55-65. PubMed ID: 33608189
[TBL] [Abstract][Full Text] [Related]
32. Auto-antibodies to type I IFNs can underlie adverse reactions to yellow fever live attenuated vaccine.
Bastard P; Michailidis E; Hoffmann HH; Chbihi M; Le Voyer T; Rosain J; Philippot Q; Seeleuthner Y; Gervais A; Materna M; de Oliveira PMN; Maia MLS; Dinis Ano Bom AP; Azamor T; Araújo da Conceição D; Goudouris E; Homma A; Slesak G; Schäfer J; Pulendran B; Miller JD; Huits R; Yang R; Rosen LB; Bizien L; Lorenzo L; Chrabieh M; Erazo LV; Rozenberg F; Jeljeli MM; Béziat V; Holland SM; Cobat A; Notarangelo LD; Su HC; Ahmed R; Puel A; Zhang SY; Abel L; Seligman SJ; Zhang Q; MacDonald MR; Jouanguy E; Rice CM; Casanova JL
J Exp Med; 2021 Apr; 218(4):. PubMed ID: 33544838
[TBL] [Abstract][Full Text] [Related]
33. Age-Related Expression of IFN-λ1
Gilbert C; Lefeuvre C; Preisser L; Pivert A; Soleti R; Blanchard S; Delneste Y; Ducancelle A; Couez D; Jeannin P
Front Immunol; 2021; 12():750279. PubMed ID: 34858406
[TBL] [Abstract][Full Text] [Related]
34. SARS-CoV-2 T Cell Response in Severe and Fatal COVID-19 in Primary Antibody Deficiency Patients Without Specific Humoral Immunity.
Steiner S; Schwarz T; Corman VM; Gebert L; Kleinschmidt MC; Wald A; Gläser S; Kruse JM; Zickler D; Peric A; Meisel C; Meyer T; Staudacher OL; Wittke K; Kedor C; Bauer S; Besher NA; Kalus U; Pruß A; Drosten C; Volk HD; Scheibenbogen C; Hanitsch LG
Front Immunol; 2022; 13():840126. PubMed ID: 35359967
[TBL] [Abstract][Full Text] [Related]
35. Clinical implications of host genetic variation and susceptibility to severe or critical COVID-19.
van der Made CI; Netea MG; van der Veerdonk FL; Hoischen A
Genome Med; 2022 Aug; 14(1):96. PubMed ID: 35986347
[TBL] [Abstract][Full Text] [Related]
36. Circulating Type I Interferon Levels in the Early Phase of COVID-19 Are Associated With the Development of Respiratory Failure.
Nagaoka K; Kawasuji H; Murai Y; Kaneda M; Ueno A; Miyajima Y; Fukui Y; Morinaga Y; Yamamoto Y
Front Immunol; 2022; 13():844304. PubMed ID: 35237279
[TBL] [Abstract][Full Text] [Related]
37. Two X-linked agammaglobulinemia patients develop pneumonia as COVID-19 manifestation but recover.
Soresina A; Moratto D; Chiarini M; Paolillo C; Baresi G; Focà E; Bezzi M; Baronio B; Giacomelli M; Badolato R
Pediatr Allergy Immunol; 2020 Jul; 31(5):565-569. PubMed ID: 32319118
[TBL] [Abstract][Full Text] [Related]
38. Antiviral Activity of Type I, II, and III Interferons Counterbalances ACE2 Inducibility and Restricts SARS-CoV-2.
Busnadiego I; Fernbach S; Pohl MO; Karakus U; Huber M; Trkola A; Stertz S; Hale BG
mBio; 2020 Sep; 11(5):. PubMed ID: 32913009
[TBL] [Abstract][Full Text] [Related]
39. Type I and Type III Interferons Restrict SARS-CoV-2 Infection of Human Airway Epithelial Cultures.
Vanderheiden A; Ralfs P; Chirkova T; Upadhyay AA; Zimmerman MG; Bedoya S; Aoued H; Tharp GM; Pellegrini KL; Manfredi C; Sorscher E; Mainou B; Lobby JL; Kohlmeier JE; Lowen AC; Shi PY; Menachery VD; Anderson LJ; Grakoui A; Bosinger SE; Suthar MS
J Virol; 2020 Sep; 94(19):. PubMed ID: 32699094
[TBL] [Abstract][Full Text] [Related]
40. Outcome of SARS-CoV-2 Infection in 121 Patients with Inborn Errors of Immunity: A Cross-Sectional Study.
Goudouris ES; Pinto-Mariz F; Mendonça LO; Aranda CS; Guimarães RR; Kokron C; Barros MT; Anísio F; Alonso MLO; Marcelino F; Valle SOR; Junior SD; Barreto IDP; Ferreira JFS; Roxo-Junior P; do Rego Silva AM; Campinhos FL; Bonfim C; Loth G; Fernandes JF; Garcia JL; Capelo A; Takano OA; Nadaf MIV; Toledo EC; Cunha LAO; Di Gesu RSW; Schidlowski L; Fillipo P; Bichuetti-Silva DC; Soldateli G; Ferraroni NR; de Oliveira Dantas E; Pestana S; Mansour E; Ulaf RG; Prando C; Condino-Neto A; Grumach AS
J Clin Immunol; 2021 Oct; 41(7):1479-1489. PubMed ID: 34164762
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
